American International Group, Inc. Biomarin Pharmaceutical Inc Transaction History

American International Group, Inc.

  • $8.5 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$83.81 - $99.0 $251 - $297
-3 Reduced 0.17%
1,728 $150,000
Q4 2023

Feb 13, 2024
SELL
$76.22 - $98.51 $3,429 - $4,432
-45 Reduced 2.53%
1,731 $166,000
Q3 2023

Nov 13, 2023
SELL
$85.07 - $94.48 $9,017 - $10,014
-106 Reduced 5.63%
1,776 $157,000
Q2 2023

Aug 04, 2023
BUY
$86.68 - $100.3 $2,080 - $2,407
24 Added 1.29%
1,882 $163,000
Q1 2023

May 12, 2023
SELL
$87.74 - $117.27 $3,509 - $4,690
-40 Reduced 2.11%
1,858 $180,000
Q4 2022

Feb 10, 2023
SELL
$80.93 - $108.63 $3,075 - $4,127
-38 Reduced 1.96%
1,898 $196,000
Q3 2022

Nov 14, 2022
BUY
$82.16 - $96.94 $410 - $484
5 Added 0.26%
1,936 $164,000
Q2 2022

Aug 12, 2022
BUY
$71.48 - $86.85 $1,644 - $1,997
23 Added 1.21%
1,931 $160,000
Q1 2022

May 13, 2022
SELL
$74.28 - $92.69 $3,862 - $4,819
-52 Reduced 2.65%
1,908 $147,000
Q4 2021

Feb 11, 2022
SELL
$71.72 - $91.47 $5,163 - $6,585
-72 Reduced 3.54%
1,960 $173,000
Q3 2021

Nov 12, 2021
SELL
$74.77 - $85.47 $18,542 - $21,196
-248 Reduced 10.88%
2,032 $157,000
Q2 2021

Aug 13, 2021
SELL
$75.51 - $84.79 $120,513 - $135,324
-1,596 Reduced 41.18%
2,280 $190,000
Q1 2021

May 07, 2021
SELL
$74.73 - $90.69 $34,076 - $41,354
-456 Reduced 10.53%
3,876 $293,000
Q4 2020

Feb 12, 2021
SELL
$72.61 - $90.2 $800,597 - $994,545
-11,026 Reduced 71.79%
4,332 $380,000
Q3 2020

Nov 04, 2020
SELL
$71.87 - $131.03 $11,427 - $20,833
-159 Reduced 1.02%
15,358 $1.17 Million
Q2 2020

Aug 12, 2020
BUY
$79.55 - $124.22 $60,855 - $95,028
765 Added 5.19%
15,517 $1.91 Million
Q1 2020

May 04, 2020
SELL
$71.37 - $96.85 $76,365 - $103,629
-1,070 Reduced 6.76%
14,752 $1.25 Million
Q4 2019

Feb 05, 2020
BUY
$64.27 - $86.37 $30,978 - $41,630
482 Added 3.14%
15,822 $1.34 Million
Q3 2019

Nov 08, 2019
BUY
$67.4 - $85.11 $4,785 - $6,042
71 Added 0.46%
15,340 $1.03 Million
Q2 2019

Aug 13, 2019
SELL
$80.35 - $93.9 $224,417 - $262,262
-2,793 Reduced 15.46%
15,269 $1.31 Million
Q1 2019

May 06, 2019
SELL
$84.2 - $98.62 $5,388 - $6,311
-64 Reduced 0.35%
18,062 $1.6 Million
Q4 2018

Feb 13, 2019
BUY
$80.14 - $106.07 $44,237 - $58,550
552 Added 3.14%
18,126 $1.54 Million
Q3 2018

Nov 09, 2018
BUY
$93.92 - $105.72 $8,546 - $9,620
91 Added 0.52%
17,574 $1.7 Million
Q2 2018

Aug 08, 2018
BUY
$76.01 - $99.03 $29,947 - $39,017
394 Added 2.31%
17,483 $1.65 Million
Q1 2018

May 07, 2018
SELL
$77.67 - $92.63 $6,834 - $8,151
-88 Reduced 0.51%
17,089 $1.39 Million
Q4 2017

Feb 09, 2018
BUY
$80.76 - $95.13 $335,477 - $395,170
4,154 Added 31.9%
17,177 $1.53 Million
Q3 2017

Nov 09, 2017
BUY
$80.6 - $94.95 $1.05 Million - $1.24 Million
13,023
13,023 $1.21 Million

Others Institutions Holding BMRN

# of Institutions
636
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.9B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email